Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0.0299044546469787
Stock impact report

BRIEF-Akers Biosciences Announces Distribution Agreement With Diagnostica Stago [Reuters]

AKERS BIOSCIENCES INC COMMON S (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
Company Research Source: Reuters
BRIEF-Akers Biosciences Announces Distribution Agreement With Diagnostica Stago? | Reuters Reuters Staff 1 Min Read March 26 (Reuters) - Akers Biosciences Inc: * ?ENTERED INTO 3-YEAR DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO FOR SALE OF CO’S RAPID TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA ACROSS US? Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. Show less Read more
Impact Snapshot
Event Time:
AKER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKER alerts
Opt-in for
AKER alerts

from News Quantified
Opt-in for
AKER alerts

from News Quantified